Current and Future Therapies Targeting the Immune System in Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|3|276-296

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.3, 2014-03, pp. : 276-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4513-4517

Bentham Science Publishers

Access to resources Recommend Favorite

Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-Mediated Repair

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1409-1417

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Therapy of Multiple Sclerosis - Future Strategies

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4489-4497

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status and Future Prospective of Immunointervention in Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 13, Iss. 19, 2006-08 ,pp. : 2329-2343

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Sclerosis: Current and Future Treatment Options

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite